Top Markets
Coin of the day
Crescent Biopharma, Inc. Crescent Biopharma, Inc.

Crescent Biopharma, Inc.

CBIO
Rankning i aktier #11763
Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and... Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a strategic alliance with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., focusing on the joint advancement and commercialization of oncology therapeutics, encompassing innovative combination approaches. The company's operations are headquartered in Waltham, Massachusetts.
Aktiekurs
$17.81
Senast synkroniserad: 2026-08-28
Marknadsvärde
$661.63M
Förändring (1 dag)
0.30%
Förändring (1 år)
23.70%
Land
US
Handel Crescent Biopharma, Inc. (CBIO)

Kategori

Historik för aktiesplit för Crescent Biopharma, Inc. (CBIO)
Aktien Crescent Biopharma, Inc. (symbol: CBIO) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 30, 2026.
En CBIO-aktie köpt före Aug 30, 2026 motsvarar nu 0 CBIO-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH